Using adaptive magnetic resonance image‐guided radiation therapy for treatment of inoperable pancreatic cancer

Adaptive magnetic resonance imaging‐guided radiation therapy (MRgRT) can escalate dose to tumors while minimizing dose to normal tissue. We evaluated outcomes of inoperable pancreatic cancer patients treated using MRgRT with and without dose escalation.

[1]  Tara Kent,et al.  Induction gemcitabine and stereotactic body radiotherapy for locally advanced nonmetastatic pancreas cancer. , 2011, International journal of radiation oncology, biology, physics.

[2]  David Goldstein,et al.  Effect of Chemoradiotherapy vs Chemotherapy on Survival in Patients With Locally Advanced Pancreatic Cancer Controlled After 4 Months of Gemcitabine With or Without Erlotinib: The LAP07 Randomized Clinical Trial. , 2016, JAMA.

[3]  I. Meszoely,et al.  Undetectable Preoperative Levels of Serum CA 19-9 Correlate with Improved Survival for Patients with Resectable Pancreatic Adenocarcinoma , 2004, Annals of Surgical Oncology.

[4]  Tianyu Zhao,et al.  Simulated Online Adaptive Magnetic Resonance-Guided Stereotactic Body Radiation Therapy for the Treatment of Oligometastatic Disease of the Abdomen and Central Thorax: Characterization of Potential Advantages. , 2016, International journal of radiation oncology, biology, physics.

[5]  Albert C Koong,et al.  Phase I study of stereotactic radiosurgery in patients with locally advanced pancreatic cancer. , 2004, International journal of radiation oncology, biology, physics.

[6]  X Allen Li,et al.  Characterization and management of interfractional anatomic changes for pancreatic cancer radiotherapy. , 2012, International journal of radiation oncology, biology, physics.

[7]  Sasa Mutic,et al.  Phase I trial of stereotactic MR-guided online adaptive radiation therapy (SMART) for the treatment of oligometastatic or unresectable primary malignancies of the abdomen. , 2017, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[8]  Tianyu Zhao,et al.  Online Magnetic Resonance Image Guided Adaptive Radiation Therapy: First Clinical Applications. , 2016, International journal of radiation oncology, biology, physics.

[9]  Jeffrey W. Clark,et al.  Intraoperative Radiotherapy in the Era of Intensive Neoadjuvant Chemotherapy and Chemoradiotherapy for Pancreatic Adenocarcinoma , 2016, American journal of clinical oncology.

[10]  J. Cameron,et al.  The Role of Stereotactic Body Radiation Therapy for Pancreatic Cancer: A Single-Institution Experience , 2015, Annals of Surgical Oncology.

[11]  Jeffrey W. Clark,et al.  "Radiological and Surgical Implications of Neoadjuvant Treatment With FOLFIRINOX for Locally Advanced and Borderline Resectable Pancreatic Cancer." , 2017, Annals of surgery.

[12]  Daniel T Chang,et al.  Stereotactic radiotherapy for unresectable adenocarcinoma of the pancreas , 2009, Cancer.

[13]  T. Desser,et al.  Single-fraction stereotactic body radiation therapy and sequential gemcitabine for the treatment of locally advanced pancreatic cancer. , 2011, International journal of radiation oncology, biology, physics.

[14]  G. Wilding,et al.  Treatment of locally advanced unresectable pancreatic cancer: a 10-year experience. , 2012, Journal of gastrointestinal oncology.

[15]  H. von der Maase,et al.  Phase-II study on stereotactic radiotherapy of locally advanced pancreatic carcinoma. , 2005, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[16]  T. Pawlik,et al.  Evaluation of predictive variables in locally advanced pancreatic adenocarcinoma patients receiving definitive chemoradiation. , 2012, Practical radiation oncology.

[17]  S. Barni,et al.  Stereotactic body radiotherapy ( SBRT ) for locally advanced pancreatic cancer : a systematic review and pooled analysis of 19 trials , 2016 .

[18]  Gabriel O Sawakuchi,et al.  Focal Radiation Therapy Dose Escalation Improves Overall Survival in Locally Advanced Pancreatic Cancer Patients Receiving Induction Chemotherapy and Consolidative Chemoradiation. , 2016, International journal of radiation oncology, biology, physics.

[19]  W. Shi,et al.  Chemotherapy and intensity-modulated radiation therapy for locally advanced pancreatic cancer achieves a high rate of R0 resection* , 2017, Acta oncologica.

[20]  Quynh-Thu Le,et al.  Phase II study to assess the efficacy of conventionally fractionated radiotherapy followed by a stereotactic radiosurgery boost in patients with locally advanced pancreatic cancer. , 2005, International journal of radiation oncology, biology, physics.

[21]  T. Desser,et al.  Gemcitabine chemotherapy and single-fraction stereotactic body radiotherapy for locally advanced pancreatic cancer. , 2008, International journal of radiation oncology, biology, physics.

[22]  J P Cuijpers,et al.  Fast and robust online adaptive planning in stereotactic MR-guided adaptive radiation therapy (SMART) for pancreatic cancer. , 2017, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[23]  Sasa Mutic,et al.  Comparison of onboard low-field magnetic resonance imaging versus onboard computed tomography for anatomy visualization in radiotherapy , 2015, Acta oncologica.

[24]  P. Parikh,et al.  Induction Chemotherapy Followed by Concurrent Full-dose Gemcitabine and Intensity-modulated Radiation Therapy for Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma , 2016, American journal of clinical oncology.